Abstract LB-A12: Results from the phase 3 study ARIEL3: mutations in non-BRCAhomologous recombination repair genes confer sensitivity to maintenance treatment with the PARP inhibitor rucaparib in patients with recurrent platinum-sensitive high-grade ovarian carcinoma

David M O'Malley, Robert L Coleman, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Iain A McNeish, Elizabeth M Swisher, Clare L Scott, Gottfried E Konecny, Heidi Giordano, Terri Cameron, Lara Maloney, Sandra Goble, James Sun, Thomas C Harding, Kevin K Lin, Jonathan A Ledermann